The prevalence of metabolic syndrome in chinese postmenopausal women and the optimum body composition indices to predict it

Menopause

Volumn 17, Issue 3, 2010, Pages 566-570

  Ruan, Xiangyan ^a   Jin, Jing ^a   Hua, Lin ^b   Liu, Yulan ^a   Wang, Juan ^a   Liu, Shunyu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Body composition; Metabolic syndrome; Postmenopausal women; Predicting

Indexed keywords

ESTRADIOL; FOLLITROPIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TRIACYLGLYCEROL;

ABDOMEN; ADULT; ANTHROPOMETRY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; BODY HEIGHT; BODY WEIGHT; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FAMILY HISTORY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; POSTMENOPAUSE; PREDICTION; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD GLUCOSE; BODY CONSTITUTION; BODY HEIGHT; BODY MASS INDEX; CAUSALITY; CHINA; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN; LIPIDS; LOGISTIC MODELS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREVALENCE; RISK FACTORS; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

EID: 77952267926     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181c8f4e1     Document Type: Article

References (25)

1. da Silva HG, Mendona LM, Conceião FL, et al. Influence of obesity on bone density in postmenopausal women. Arq Bras Endocrinol Metabol 2007;51:943-949.
2. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimeno-pausal women. J Clin Endocrinol Metab 2002;87:4166-4170.
3. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. J Endocrinol Invest 2004; 27:648-653.
4. Gaspard U. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women. Maturitas 2009;62:362-365.
5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, for the National Heart, Lung, and Blood Institute. Definition of the metabolic syndrome. NHLBI/AHA Conference Proceedings. Circulation 2004;109: 433-438.
6. Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA, for the American Heart Association. Clinical management of the metabolic syndrome. NHLBI/AHA Conference Proceedings. Circulation 2004; 109:551-556.
7. Metabolic syndrome research cooperation writing group of Chinese medical association diabetes branch. The advice on metabolic syndrome from Chinese medical association diabetes branch [in Chinese]. Chin J Diabetes 2004;12:156-161.
8. Chedraui P, Hidalgo L, Chavez D, et al. Quality of life among post-menopausal Ecuadorian women participating in a metabolic syndrome screening program. Maturitas 2007;56:45-53.
9. Ding QF, Hayashi T, Zhang XJ, et al. Risks of CHD identified by different criteria of metabolic syndrome and related changes of adipo-cytokines in elderly postmenopausal women. J Diabetes Complications 2007;21:315-319.
10. Ponholzer A, Temml C, Rauchenwald M, et al. Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women? Int J Impot Res 2008;20:100-104.
11. Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524-529.
12. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007;77:471-478.
13. Rossi R, Nuzzo A, Oriqliani G, et al. Metabolic syndrome affects cardiovascular risk profile and response to treatment in hypertensive post-menopausal women. Hypertension 2008;52:865-872.
14. Llaneza P, González C, Fernandez-Iñarrea J, Alonso A, Arnott I, Ferrer-Barriendos J. Insulin resistance and health-related quality of life in postmenopausal women. Fertil Steril 2009;91:1370-1373.
15. Alberti KG, Zimmet PZ, Shaw JE. The metabolic syndrome a new world-wide definition from the International Diabetes Federation consensus. Lancet 2005;183:175-176.
16. Konukoglu D, Serin O, Ercan M, et al. The relationship between plasma viscosity and cholesterol in postmenopausal women on hormone replacement therapy. Clin Hemorheol Microcirc 2000;22:223-228. (Pubitemid 30618329)
17. Gu DF, Reynolds K, Yang WJ, et al. The prevalence of metabolic syndrome in the general adult population aged 35-74 years in China [in Chinese]. Chin J Diabetes 2005;13:181-186.
18. Shi H, Cleqq DJ. Sex differences in the regulation of body weight. Physiol Behav 2009;97:199-204.
19. Phillips GB, Jing T, Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 2008;57:838-844.
20. Behnke AR Jr, Feen BG, Welham WC. The specific gravity of healthy men. Body weight divided by volume as an index of obesity. Obes Res 1995;3:295-300.
21. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.
22. Despres JP, Lemieux I, Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001;322:716-720.
23. Deibert P, König D, Vitolins MZ, et al. Effect of a weight loss intervention on anthropometric measures and metabolic risk factors in pre-versus postmenopausal women. Nutr J 2007;25:31.
24. Wildman RP, Gu D, Reynolds K, et al. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr 2004;80:1129-1136.
25. Torrens JI, Skurnick J, Davidow AL, et al. Ethnic differences in insulin sensitivity and A-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004;27:354-361.